InsiderTrades

Form 4 for XYL Xylem Inc.

Accepted 2021-07-16 00:00:00 ET · period of report 2021-07-15 · accession 0001209191-21-046897 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-16 2021-07-15 XYL Toussaint Claudia S SVP, CSO, Gen Counsel, Corp Sec M - OptEx $48.33 +5,956 59.1K +11% +$287.9K
D 2021-07-16 2021-07-15 XYL Toussaint Claudia S SVP, CSO, Gen Counsel, Corp Sec S - Sale+OE $120.12 -5,956 53.1K -10% -$715.4K
D 2021-07-16 2021-07-15 XYL Toussaint Claudia S SVP, CSO, Gen Counsel, Corp Sec M - OptEx $0.00 -5,956 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-15 M A 5,956 $48.33 59,065 D — —
2 Common Common Stock 2021-07-15 S D 5,956 $120.12 53,109 D — — (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 15, 2021. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,407 Shares were executed at a range of prices from $118.92 to $119.91. 2,849 Shares were executed at a range of prices from $119.94 to $120.93. 700 Shares were executed at a range of prices from $120.94 to $121.25. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. (F3) Includes 48,065 shares held by the Claudia S. Toussaint Revocable Trust.
3 Derivative Stock Option (Right to Buy) 2021-07-15 M D 5,956 $0.00 0 D $48.33 · — to 2027-02-21 5,956 Common (F4) These options are fully vested and exercisable.